Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 15/20 | 0.62 |
| ▸ | CTSL | P07711 | 14/20 | 0.62 |
| ▸ | CTSB | P07858 | 12/20 | 0.62 |
| ▸ | CTSK | P43235 | 9/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2822302 | 0.94 | CTSS (0.70) | CTSSCTSLCTSBCTSK | |
| SCHEMBL2401471 | 0.83 | CTSL (0.53) | CTSSCTSLCTSBCTSK | |
| SCHEMBL2401476 | 0.83 | CTSL (0.53) | CTSSCTSLCTSBCTSK | |
| SCHEMBL1272500 | 0.83 | CTSS (0.88) | CTSSCTSLCTSBCTSK | |
| SCHEMBL14324339 | 0.83 | CTSS (0.88) | CTSSCTSLCTSBCTSK | |
| SCHEMBL15827682 | 0.83 | CTSL (0.70) | CTSSCTSLCTSBCTSK | |
| SCHEMBL1273049 | 0.82 | CTSL (0.39) | CTSSCTSLCTSBCTSK | |
| SCHEMBL1273048 | 0.82 | CTSL (0.39) | CTSSCTSLCTSBCTSK | |
| SCHEMBL1333119 | 0.81 | CTSL (0.54) | CTSSCTSLCTSBCTSK | |
| SCHEMBL2132609 | 0.81 | CTSL (0.78) | CTSSCTSLCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1866277-B1 | SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | VIROBAY INC (US) | 2014-06-25 | — | — | EP | disclosed |
| US-20120329837-A1 | CATHEPSIN INHIBITORS FOR TREATING MICROGLIA-MEDIATED NEURON LOSS IN THE CENTRAL NERVOUS SYSTEM | VIROBAY, INC. (US) | 2012-12-27 | — | — | US | disclosed |
| US-20110281879-A1 | SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | VIROBAY, INC. (US) | 2011-11-17 | — | — | US | disclosed |
| US-7893093-B2 | Sulfonyl containing compounds as cysteine protease inhibitors | VIROBAY, INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-20080287446-A1 | Sulfonyl Containing Compounds as Cysteine Protease Inhibitors | QUEST DIAGNOSTICS INVESTMENTS LLC | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110281879-A1 | SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | CTSS, CTSF, CTSB | CTSS 1/4885CTSL 10/4885CTSB 3/4885 |
| US-20080287446-A1 | Sulfonyl Containing Compounds as Cysteine Protease Inhibitors | CTSS, CTSF, CTSB | CTSS 1/4885CTSL 10/4885CTSB 3/4885 |
| US-20120329837-A1 | CATHEPSIN INHIBITORS FOR TREATING MICROGLIA-MEDIATED NEURON LOSS IN THE CENTRAL NERVOUS SYSTEM | CTSS, CTSB, CTSG | CTSS 1/4885CTSL 12/4885CTSB 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.